.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Yummi Karma is stocked at 205 licensed dispensaries across California, with the deepest coverage in Los Angeles, San Bernardino, San Francisco, Corona, and Long Beach. Search by ZIP code or city below to find the closest one.
Market Insights Snapshot
In August 2026, Yummi Karma operated as a single-category brand with Tincture & Sublingual accounting for 100.0% share, pairing a 15.09% year-over-year sales increase with a -6.33% month-over-month pullback. The category’s average price of $33.90 sat alongside a -4.78% YoY price change, indicating volume expansion despite lower unit pricing; together with a rank of 2 in Tincture & Sublingual in California, the mix suggests concentrated strength within one format while absorbing short-term monthly volatility.
The combination of full-category concentration at 100.0% and a rank of 2 in Tincture & Sublingual in California implies a defensible specialist position, aided by 15.09% YoY sales growth despite a -4.78% YoY price cut. The -6.33% MoM dip paired with category exclusivity signals exposure to intra-category seasonality and pricing moves; sustaining the August 2026 standing likely depends on leveraging volume gains from lower pricing while managing the trade-off that kept average price at $33.90.
Competitive Landscape
Yummi Karma sits at rank #2 in California Tincture & Sublingual for August 2026, unchanged from #2 a year earlier, and it also held #2 three months ago, indicating a flat rank trajectory despite category churn; in contrast, Papa & Barkley stayed at #1 while posting a -1.36% year-over-year sales change, and Care By Design remained at #3 with a -14.04% sales decline, suggesting Yummi Karma’s stable #2 is buffered by top and lower-tier softness, while VET CBD at #4 with +12.37% sales growth and Mary's Medicinals moving from #6 to #5 with +6.80% could compress the gap from below; the pattern implies Yummi Karma’s steady #2 rank with 0 positions gained year over year buys time, but accelerating mid-pack growth pressures the brand to convert stability into upward share capture rather than defending a static position.
Notable Products
CBG/CBD/THC 10:10:1 Bright Side Dragonfruit Tincture (300mg CBG, 300mg CBD, 30mg THC, 30ml) posted the steepest decline in August 2026 at -26.97% and slipped within the top ten at rank 10, while Drift Away Bedtime Tincture (300mg THC, 30ml) fell -21.87% at rank 2, signaling softness in non-flagship formats. Lights Out Marshmallow Natural Sleep Tincture (1000mg THC, 30ml) held rank 1 with a -1.03% MoM dip and approximately $121,368 in sales, contrasting with mid-pack gains such as Birthday Cake Tincture (1000mg THC, 30ml) at +13.94% and CBD/THC 30:1 Just Peachy Tincture (1000mg CBD, 30mg THC, 30ml) at +18.95%. Eight of the top ten are Tincture & Sublingual SKUs, yet the mixed performance—two declines worse than -20% and three gains above +10%—implies the portfolio is consolidating around a single anchor while secondary sleep and minor-cannabinoid entries require repositioning. The pattern indicates Yummi Karma is oriented toward high-THC sleep leadership with selective flavor-led extensions, and near-term commercial direction likely benefits from pruning weaker minor-cannabinoid SKUs and reinforcing the flagship halo.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
